Halcon Resources Corporation (NYSE:HK) was downgraded by analysts at Barclays from an “equal weight” rating to an “underweight” rating in a research report issued to clients and investors on Wednesday. They currently have a $0.50 price target on the stock, down from their previous price target of $1.50. Barclays’ price target indicates a potential downside of 66.44% from the stock’s previous close. On Friday shares of Halcon Resources Corporation (NYSE:HK) closed at $1.20. Company’s sales growth for last 5 years was 37.20%
On 15 January Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) announced its plans to increase its capital expenditures to US$11.5 billion to US$12 billion this year, compared to US$9.52 billion in 2014. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) in last trading activity moved down -1.27% to close at $22.60. Company weekly performance is 6.60% while its quarterly performance stands at 9.07%. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is -3.99% away from its 52 week high.
On 11 January Seaspan Corporation (NYSE:SSW) reported the MOL Express, a 4,600 TEU container vessel went aground in Tateyama Harbour, Japan. The company said all preliminary reports indicate the hull is in a stable condition, and no environmental damage has occurred. There were no reported crew injuries. Seaspan and MOL, with the assistance of salvage experts, are working on refloating the vessel. On last trading day Seaspan Corporation (NYSE:SSW) increased 0.28% to close at $18.03. Its volatility for the week is 3.05% while volatility for the month is 3.10%. SSW’s sales growth for past 5 years was 24.20% and its EPS growth for past 5 years was 24.10%. Seaspan Corporation (NYSE:SSW) monthly performance is 0.06%.
OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) SVP Jakob Dupont sold 1,500 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $25.89, for a total transaction of $38,835.00. Following the sale, the senior vice president now directly owns 21,620 shares in the company, valued at approximately $559,741.80. OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) has 0.70% insider ownership while its institutional ownership stands at 83.50%. In last trading activity company’s stock closed at $23.57.
On 8 January Tucows Inc. (NASDAQ:TCX) said that it will purchase 193,907 shares of its common stock at a purchase price of $18.50 per share, for a total cost of $3,587,280, excluding fees and expenses related to the tender offer. Payment for shares accepted for purchase will be funded in cash. On last trading day Tucows Inc. (NASDAQ:TCX) moved down -0.05% to close at $18.90. Its volatility for the week is 1.79% while volatility for the month is 2.69%. TCX’s sales growth for past 5 years was 10.60% and its EPS growth for past 5 years was 27.50%. Tucows Inc. (NASDAQ:TCX) monthly performance is 4.13%.